Through the Looking Glass: The Paradoxical Evolution of Targeted Temperature Management for Comatose Survivors of Cardiac Arrest

Neurotherapeutics. 2022 Oct;19(6):1869-1877. doi: 10.1007/s13311-022-01315-7. Epub 2022 Oct 17.

Abstract

For the past two decades, targeted temperature management (TTM) has been a staple in the care of comatose survivors following cardiac arrest. However, recent clinical trials have failed to replicate the benefit seen in earlier studies, bringing into question the very existence of such clinical practice. In this review, we explore clinical scenarios within critical care that appeared to share a similar fate, but in actuality changed the landscape of practice in a modern world. Accordingly, clinicians may apply these lessons to the utilization of TTM among comatose survivors following cardiac arrest, potentially paving way for a re-framing of clinical care amidst an environment where current data appears upside down in comparison to past successes.

Keywords: Cardiac arrest; Hypothermia; Neuroprotection; Targeted temperature management.

Publication types

  • Review

MeSH terms

  • Coma / etiology
  • Coma / therapy
  • Critical Care
  • Heart Arrest* / complications
  • Heart Arrest* / therapy
  • Humans
  • Hypothermia, Induced*
  • Survivors